VORTIOXETINE

VORTIOXETINE was reported 17188 times

VORTIOXETINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DYSTONIC TREMOR 30 0.3409
1 DECOMPRESSION SICKNESS 17 0.3333
2 NEUROGLYCOPENIA 30 0.2727
3 AMAUROSIS FUGAX 222 0.2061
4 APHANTASIA 8 0.1509
5 COLLOID BRAIN CYST 6 0.1333
6 FEELING GUILTY 173 0.1311
7 PERIPHERAL CIRCULATORY FAILURE 35 0.0854
8 PAINFUL EJACULATION 12 0.0531
9 ALCOHOLIC 10 0.0503
10 CENTRAL PAIN SYNDROME 13 0.0491
11 MULTIPLE DRUG THERAPY 36 0.0477
12 URINARY TRACT DISORDER 197 0.0437
13 HYPERPHAGIA 168 0.0421
14 ACTIVATION SYNDROME 12 0.0347
15 HAEMORRHAGIC STROKE 242 0.0310
16 MYOGLOBINURIA 16 0.0300
17 HYPERALDOSTERONISM 9 0.0261
18 ABULIA 22 0.0238
19 OCULAR DISCOMFORT 247 0.0220
20 CARDIOSPASM 12 0.0215
21 DISSOCIATIVE DISORDER 15 0.0208
22 APATHY 288 0.0197
23 BLOOD CHOLESTEROL DECREASED 31 0.0166
24 PALMOPLANTAR KERATODERMA 12 0.0166
25 GENERALISED OEDEMA 205 0.0165
26 EJACULATION DELAYED 9 0.0161
27 PERINEAL PAIN 11 0.0154
28 FEELINGS OF WORTHLESSNESS 20 0.0153
29 LABELLED DRUG-DRUG INTERACTION ISSUE 22 0.0152
30 EXECUTIVE DYSFUNCTION 8 0.0148
31 SEXUAL DYSFUNCTION 168 0.0143
32 GASTRIC POLYPS 32 0.0142
33 HEAD DISCOMFORT 247 0.0139
34 REDUCED FACIAL EXPRESSION 14 0.0138
35 DRUG-DISEASE INTERACTION 10 0.0136
36 ANORGASMIA 37 0.0136
37 SEROTONIN SYNDROME 260 0.0135
38 INTRUSIVE THOUGHTS 15 0.0127
39 PRODUCT INEFFECTIVE 10 0.0127
40 ALCOHOL USE 46 0.0125
41 RESTING TREMOR 8 0.0124
42 BLUNTED AFFECT 9 0.0122
43 NEGATIVISM 9 0.0119
44 FEMALE STERILISATION 6 0.0117
45 ANGER 394 0.0116
46 ALTERED STATE OF CONSCIOUSNESS 243 0.0112
47 BINGE EATING 12 0.0111
48 STUPOR 35 0.0109
49 DISSOCIATION 83 0.0108
50 STARVATION 9 0.0108
51 SUICIDAL IDEATION 969 0.0106
52 DEPRESSIVE SYMPTOM 37 0.0105
53 ORGASM ABNORMAL 8 0.0099
54 AKATHISIA 135 0.0099
55 BRUXISM 52 0.0096
56 PHOTOPHOBIA 180 0.0096
57 DISTRACTIBILITY 11 0.0095
58 HAEMATEMESIS 241 0.0095
59 HYPERSOMNIA 265 0.0092
60 PARKINSONISM 89 0.0091
61 DIPLOPIA 231 0.0089
62 GENITAL HYPOAESTHESIA 9 0.0088
63 DISTURBANCE IN ATTENTION 473 0.0088
64 DISTURBANCE IN SEXUAL AROUSAL 8 0.0087
65 TACHYPHRENIA 30 0.0087
66 ENERGY INCREASED 50 0.0085
67 CONTRAINDICATED PRODUCT PRESCRIBED 14 0.0083
68 IMPULSE-CONTROL DISORDER 17 0.0083
69 PRESYNCOPE 197 0.0081
70 ATRIOVENTRICULAR BLOCK FIRST DEGREE 35 0.0081
71 LIBIDO INCREASED 16 0.0079
72 HYPOMANIA 29 0.0079
73 NEGATIVE THOUGHTS 23 0.0078
74 MAJOR DEPRESSION 57 0.0078
75 MOOD SWINGS 241 0.0076
76 ASCITES 221 0.0075
77 REFLUX GASTRITIS 9 0.0075
78 IRRITABILITY 427 0.0071
79 GAMBLING DISORDER 19 0.0070
80 LIBIDO DISORDER 9 0.0069
81 MUSCLE CONTRACTURE 14 0.0069
82 DRUG SCREEN FALSE POSITIVE 19 0.0069
83 EMOTIONAL POVERTY 12 0.0068
84 MANIA 111 0.0067
85 BRADYKINESIA 39 0.0066
86 INITIAL INSOMNIA 67 0.0065
87 PRODUCT NAME CONFUSION 7 0.0064
88 DISTURBANCE IN SOCIAL BEHAVIOUR 15 0.0064
89 BLOOD CREATINE INCREASED 28 0.0063
90 ESSENTIAL TREMOR 7 0.0063
91 SEDATION COMPLICATION 16 0.0063
92 TINNITUS 284 0.0062
93 HAEMATURIA 210 0.0061
94 FLAT AFFECT 14 0.0060
95 BLINDNESS 245 0.0060
96 SELF-INJURIOUS IDEATION 25 0.0060
97 HOMICIDAL IDEATION 24 0.0059
98 SLEEP TALKING 10 0.0059
99 FEELING OF DESPAIR 27 0.0058
100 SLOW SPEECH 14 0.0058
101 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 59 0.0057
102 ATRIAL TACHYCARDIA 12 0.0057
103 STERNAL FRACTURE 7 0.0057
104 VICTIM OF CRIME 7 0.0057
105 HYPERACUSIS 21 0.0056
106 METABOLIC ALKALOSIS 9 0.0056
107 PRURITUS GENITAL 13 0.0055
108 CARDIO-RESPIRATORY ARREST 230 0.0055
109 DECREASED INTEREST 32 0.0054
110 DRUG TITRATION ERROR 14 0.0054
111 LONG QT SYNDROME 13 0.0054
112 COMPULSIVE SHOPPING 11 0.0053
113 SEIZURE LIKE PHENOMENA 9 0.0053
114 SUICIDE ATTEMPT 320 0.0053
115 SLEEP TERROR 22 0.0052
116 ALCOHOL INTERACTION 10 0.0051
117 SUSPECTED SUICIDE 24 0.0051
118 COMA 242 0.0051
119 SUICIDAL BEHAVIOUR 21 0.0050
120 ELECTRIC SHOCK SENSATION 14 0.0050
121 EYE PAIN 281 0.0050
122 SEDATION 130 0.0050
123 GLUTEN SENSITIVITY 7 0.0049
124 VOMITING PROJECTILE 14 0.0048
125 RESTLESS LEGS SYNDROME 87 0.0048
126 SLEEP PARALYSIS 7 0.0048
127 GUN SHOT WOUND 9 0.0047
128 PRODUCT ADMINISTRATION INTERRUPTED 37 0.0047
129 PUPIL FIXED 8 0.0046
130 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 28 0.0046
131 VIOLENCE-RELATED SYMPTOM 7 0.0045
132 SUBSTANCE USE 7 0.0045
133 EATING DISORDER 95 0.0045
134 PSYCHOTIC SYMPTOM 9 0.0044
135 MICTURITION DISORDER 15 0.0043
136 PSYCHOMOTOR RETARDATION 12 0.0043
137 NARCOLEPSY 8 0.0042
138 PEPTIC ULCER 14 0.0042
139 PERSONALITY DISORDER 11 0.0042
140 MUSCLE RIGIDITY 50 0.0042
141 PRE-EXISTING CONDITION IMPROVED 26 0.0042
142 SOCIAL AVOIDANT BEHAVIOUR 24 0.0041
143 PANIC DISORDER 16 0.0041
144 PRURITUS GENERALISED 89 0.0041
145 BIPOLAR DISORDER 44 0.0040
146 NIGHTMARE 139 0.0040
147 TACHYCARDIA 356 0.0040
148 PANIC ATTACK 146 0.0040
149 TENSION HEADACHE 17 0.0039
150 HOSTILITY 10 0.0039
151 OBSESSIVE-COMPULSIVE DISORDER 31 0.0039
152 HYPERSEXUALITY 7 0.0038
153 BRADYPHRENIA 25 0.0038
154 FOOD CRAVING 20 0.0038
155 CRYING 138 0.0038
156 NEUROLEPTIC MALIGNANT SYNDROME 45 0.0038
157 MOTOR DYSFUNCTION 38 0.0037
158 DEREALISATION 8 0.0037
159 AUTOIMMUNE THYROIDITIS 14 0.0037
160 ANXIETY 1053 0.0037
161 GASTRIC BYPASS 8 0.0037
162 BIPOLAR I DISORDER 8 0.0036
163 RESTLESSNESS 132 0.0036
164 PRESCRIBED OVERDOSE 69 0.0036
165 ABNORMAL DREAMS 98 0.0035
166 ERECTILE DYSFUNCTION 91 0.0035
167 INSOMNIA 942 0.0035
168 ANGLE CLOSURE GLAUCOMA 9 0.0035
169 CARDIAC DISCOMFORT 7 0.0035
170 DEPRESSION 786 0.0035
171 COMPLETED SUICIDE 286 0.0034
172 BREAST DISCHARGE 6 0.0034
173 LOGORRHOEA 12 0.0034
174 HALLUCINATION, AUDITORY 54 0.0034
175 HIATUS HERNIA 44 0.0034
176 AGITATION 249 0.0034
177 YAWNING 9 0.0034
178 FEELING JITTERY 63 0.0033
179 THINKING ABNORMAL 61 0.0033
180 BODY TEMPERATURE ABNORMAL 6 0.0033
181 POSTOPERATIVE WOUND INFECTION 22 0.0033
182 TEARFULNESS 14 0.0033
183 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 23 0.0032
184 IMPULSIVE BEHAVIOUR 12 0.0032
185 DEPRESSED MOOD 168 0.0032
186 BLEPHAROSPASM 20 0.0032
187 IMPAIRED GASTRIC EMPTYING 43 0.0032
188 MENTAL IMPAIRMENT 75 0.0031
189 SYNCOPE 304 0.0030
190 MUSCLE TWITCHING 70 0.0030
191 CAROTID ARTERY OCCLUSION 11 0.0030
192 TEMPOROMANDIBULAR JOINT SYNDROME 8 0.0030
193 FRUSTRATION TOLERANCE DECREASED 24 0.0030
194 URINARY RETENTION 99 0.0030
195 SLEEP APNOEA SYNDROME 56 0.0029
196 DRUG INTERACTION 465 0.0029
197 URINE FLOW DECREASED 7 0.0029
198 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 15 0.0029
199 TARDIVE DYSKINESIA 82 0.0029
200 WITHDRAWAL SYNDROME 122 0.0029
201 NO ADVERSE EVENT 524 0.0029
202 NAUSEA 2284 0.0029
203 FEELING ABNORMAL 686 0.0029
204 MIDDLE INSOMNIA 53 0.0028
205 DEVICE INFUSION ISSUE 7 0.0028
206 AFFECT LABILITY 27 0.0028
207 HYPOTONIA 28 0.0028
208 PERSONALITY CHANGE 26 0.0028
209 HALLUCINATION, VISUAL 59 0.0028
210 POOR QUALITY SLEEP 60 0.0028
211 DROOLING 19 0.0027
212 DEAFNESS NEUROSENSORY 9 0.0027
213 HUNGER 38 0.0027
214 DEMENTIA 76 0.0027
215 CEREBRAL DISORDER 20 0.0027
216 WEIGHT INCREASED 603 0.0027
217 LOSS OF LIBIDO 24 0.0027
218 CATATONIA 14 0.0027
219 BLOOD PRESSURE INCREASED 407 0.0027
220 CHILLS 311 0.0027
221 VISION BLURRED 361 0.0026
222 INABILITY TO AFFORD MEDICATION 26 0.0026
223 BREAST SWELLING 7 0.0026
224 SOMNAMBULISM 17 0.0026
225 METABOLIC DISORDER 15 0.0026
226 DYSTONIA 50 0.0026
227 THERAPEUTIC PRODUCT EFFECT VARIABLE 10 0.0026
228 BLOOD PROLACTIN INCREASED 12 0.0025
229 HAEMORRHAGIC DIATHESIS 9 0.0025
230 SOMNOLENCE 501 0.0025
231 PRODUCT PRESCRIBING ERROR 59 0.0025
232 ENURESIS 10 0.0025
233 PSYCHOMOTOR HYPERACTIVITY 41 0.0025
234 COGNITIVE DISORDER 114 0.0024
235 ANHEDONIA 64 0.0024
236 BLOOD IMMUNOGLOBULIN G DECREASED 6 0.0024
237 GENERALISED TONIC-CLONIC SEIZURE 40 0.0024
238 HYPERHIDROSIS 311 0.0024
239 MELAENA 53 0.0024
240 LYME DISEASE 8 0.0024
241 THERAPEUTIC REACTION TIME DECREASED 7 0.0024
242 SALIVARY HYPERSECRETION 24 0.0024
243 PREGNANCY 48 0.0024
244 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
245 PARANASAL SINUS DISCOMFORT 9 0.0024
246 BRAIN FOG 37 0.0024
247 SHOULDER OPERATION 10 0.0023
248 MYDRIASIS 30 0.0023
249 DEPRESSION SUICIDAL 8 0.0023
250 VULVOVAGINAL MYCOTIC INFECTION 9 0.0023
251 SEPSIS 255 0.0023
252 APPENDICECTOMY 8 0.0022
253 TRIGEMINAL NEURALGIA 9 0.0022
254 POST-TRAUMATIC STRESS DISORDER 15 0.0022
255 VOMITING 1036 0.0022
256 DIABETES MELLITUS INADEQUATE CONTROL 39 0.0022
257 CONCUSSION 17 0.0022
258 CLONUS 6 0.0022
259 EUGLYCAEMIC DIABETIC KETOACIDOSIS 9 0.0022
260 HYPERPROLACTINAEMIA 14 0.0022
261 DRUG EFFECT LESS THAN EXPECTED 32 0.0022
262 INSURANCE ISSUE 33 0.0022
263 FEELING DRUNK 16 0.0022
264 BLOOD UREA INCREASED 36 0.0021
265 EUPHORIC MOOD 22 0.0021
266 DRY MOUTH 174 0.0021
267 DEFAECATION URGENCY 15 0.0021
268 ATTENTION DEFICIT HYPERACTIVITY DISORDER 9 0.0021
269 THERAPY CHANGE 21 0.0021
270 FACIAL PAIN 19 0.0021
271 MIGRAINE 203 0.0021
272 ELECTROCARDIOGRAM QT PROLONGED 76 0.0021
273 ASTHENIA 792 0.0021
274 PRURITUS 806 0.0021
275 ANXIETY DISORDER 7 0.0021
276 HYPONATRAEMIA 118 0.0021
277 ABDOMINAL PAIN UPPER 431 0.0021
278 ADVERSE DRUG REACTION 187 0.0021
279 COMA SCALE ABNORMAL 6 0.0021
280 RETCHING 44 0.0021
281 THERAPY INTERRUPTED 147 0.0021
282 UNDERDOSE 150 0.0021
283 INTENTIONAL OVERDOSE 130 0.0020
284 DRUG SCREEN POSITIVE 16 0.0020
285 THERAPY NON-RESPONDER 91 0.0020
286 MUCOUS STOOLS 10 0.0020
287 SURGERY 118 0.0020
288 HYPERREFLEXIA 7 0.0020
289 MENTAL DISORDER 87 0.0020
290 INCREASED APPETITE 38 0.0020
291 EMBOLIC STROKE 7 0.0020
292 CRANIOCEREBRAL INJURY 6 0.0020
293 MYALGIA 335 0.0020
294 TREMOR 327 0.0020
295 CONSTIPATION 425 0.0019
296 DRUG PRESCRIBING ERROR 37 0.0019
297 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17 0.0019
298 BLOOD POTASSIUM INCREASED 31 0.0019
299 ARTHROPOD BITE 14 0.0019
300 RESPIRATION ABNORMAL 13 0.0019
301 SCREAMING 12 0.0019
302 INTENTIONAL SELF-INJURY 38 0.0019
303 HYPOVOLAEMIA 11 0.0019
304 BLOOD SODIUM DECREASED 35 0.0019
305 ANAL ABSCESS 10 0.0019
306 ATAXIA 22 0.0019
307 MYOPATHY 16 0.0019
308 HYSTERECTOMY 16 0.0018
309 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
310 DYSURIA 67 0.0018
311 DIZZINESS 904 0.0018
312 DECREASED APPETITE 420 0.0018
313 APHTHOUS ULCER 14 0.0018
314 HEART RATE ABNORMAL 10 0.0018
315 SPINAL OPERATION 22 0.0018
316 SKIN INFECTION 20 0.0018
317 ORTHOSTATIC HYPOTENSION 31 0.0018
318 IMPAIRED WORK ABILITY 38 0.0018
319 SUBARACHNOID HAEMORRHAGE 18 0.0018
320 FALL 588 0.0018
321 ACCIDENT 21 0.0018
322 OSTEOPOROSIS 72 0.0017
323 INFUSION SITE SWELLING 11 0.0017
324 PARANOIA 30 0.0017
325 HALLUCINATION 131 0.0017
326 DELUSION 27 0.0017
327 MUSCLE TIGHTNESS 28 0.0017
328 PSYCHOTIC DISORDER 51 0.0017
329 FEEDING DISORDER 35 0.0017
330 SPINAL FUSION SURGERY 7 0.0017
331 DISABILITY 34 0.0017
332 THERAPEUTIC PRODUCT EFFECT DECREASED 77 0.0017
333 HEADACHE 1075 0.0017
334 GLOSSITIS 6 0.0017
335 SLUGGISHNESS 17 0.0017
336 BEHAVIOUR DISORDER 9 0.0017
337 APPETITE DISORDER 11 0.0017
338 CONTUSION 159 0.0016
339 TIC 9 0.0016
340 SLEEP DISORDER 116 0.0016
341 VITAMIN D DEFICIENCY 16 0.0016
342 WRONG PRODUCT ADMINISTERED 11 0.0016
343 INTERVERTEBRAL DISC DEGENERATION 15 0.0016
344 AGGRESSION 81 0.0016
345 HYPERNATRAEMIA 8 0.0016
346 BRAIN INJURY 16 0.0016
347 PAROSMIA 12 0.0016
348 MOOD ALTERED 43 0.0016
349 MICTURITION URGENCY 18 0.0016
350 DYSKINESIA 64 0.0016
351 FATIGUE 1225 0.0016
352 MENSTRUAL DISORDER 13 0.0016
353 SEIZURE 181 0.0016
354 HYPOGLYCAEMIA 76 0.0016
355 ABDOMINAL PAIN 363 0.0016
356 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 111 0.0016
357 GALACTORRHOEA 10 0.0016
358 HEAVY MENSTRUAL BLEEDING 14 0.0016
359 FAECES HARD 6 0.0015
360 FEELING OF BODY TEMPERATURE CHANGE 9 0.0015
361 MULTIPLE ALLERGIES 12 0.0015
362 NIGHT SWEATS 49 0.0015
363 HYPOKINESIA 22 0.0015
364 EXPOSURE VIA BREAST MILK 6 0.0015
365 PRESCRIBED UNDERDOSE 30 0.0015
366 PALPITATIONS 176 0.0015
367 ANAL FISSURE 8 0.0015
368 PRODUCT RESIDUE PRESENT 8 0.0015
369 DECREASED ACTIVITY 16 0.0015
370 TENSION 9 0.0015
371 GASTROINTESTINAL DISORDER 132 0.0015
372 THERAPY CESSATION 75 0.0015
373 EYE MOVEMENT DISORDER 10 0.0015
374 APHASIA 44 0.0015
375 ANOSMIA 21 0.0014
376 OBESITY 23 0.0014
377 HYPERTHERMIA 11 0.0014
378 CONDITION AGGRAVATED 438 0.0014
379 NERVOUSNESS 75 0.0014
380 MYOCLONUS 17 0.0014
381 HOSPITALISATION 219 0.0014
382 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 288 0.0014
383 WRIST FRACTURE 17 0.0014
384 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 68 0.0014
385 MEMORY IMPAIRMENT 193 0.0014
386 ALCOHOLISM 6 0.0014
387 AFFECTIVE DISORDER 11 0.0014
388 SCHIZOPHRENIA 17 0.0014
389 INFUSION SITE PAIN 18 0.0014
390 PANCREATITIS ACUTE 31 0.0014
391 VASCULITIS 16 0.0014
392 DIVERTICULUM INTESTINAL 6 0.0014
393 PRODUCT COLOUR ISSUE 7 0.0014
394 EMOTIONAL DISORDER 42 0.0014
395 FIBROMYALGIA 33 0.0014
396 BACK DISORDER 22 0.0014
397 MEDICATION ERROR 75 0.0013
398 ABDOMINAL DISCOMFORT 225 0.0013
399 AMNESIA 87 0.0013
400 SYMPTOM RECURRENCE 8 0.0013
401 PRODUCT USE IN UNAPPROVED INDICATION 330 0.0013
402 DRUG LEVEL INCREASED 22 0.0013
403 EOSINOPHIL COUNT INCREASED 11 0.0013
404 DIARRHOEA 850 0.0013
405 LIGAMENT SPRAIN 13 0.0013
406 FLATULENCE 74 0.0013
407 ARTHRITIS INFECTIVE 6 0.0013
408 FORMICATION 9 0.0013
409 PRODUCT USE ISSUE 242 0.0013
410 THERAPY PARTIAL RESPONDER 20 0.0013
411 SKIN HAEMORRHAGE 19 0.0013
412 BODY TEMPERATURE INCREASED 26 0.0013
413 SWELLING OF EYELID 8 0.0013
414 GASTROENTERITIS VIRAL 23 0.0013
415 GASTROINTESTINAL PAIN 14 0.0013
416 CYSTIC FIBROSIS 7 0.0013
417 ILLNESS 130 0.0013
418 GESTATIONAL DIABETES 6 0.0013
419 COUGH 353 0.0013
420 ENDOMETRIOSIS 6 0.0013
421 URINE OUTPUT DECREASED 11 0.0013
422 MOBILITY DECREASED 90 0.0013
423 GROIN PAIN 11 0.0013
424 IMPAIRED QUALITY OF LIFE 18 0.0013
425 BALANCE DISORDER 108 0.0012
426 PANIC REACTION 9 0.0012
427 DIZZINESS POSTURAL 12 0.0012
428 INCOHERENT 8 0.0012
429 HERPES SIMPLEX 8 0.0012
430 JOINT DISLOCATION 13 0.0012
431 DERMATITIS CONTACT 14 0.0012
432 ANKLE FRACTURE 19 0.0012
433 ARTHRALGIA 509 0.0012
434 COELIAC DISEASE 12 0.0012
435 ANAL INCONTINENCE 11 0.0012
436 KNEE OPERATION 12 0.0012
437 GASTROOESOPHAGEAL REFLUX DISEASE 98 0.0012
438 FOOT OPERATION 6 0.0012
439 DIABETIC NEUROPATHY 6 0.0012
440 GASTROINTESTINAL SOUNDS ABNORMAL 6 0.0012
441 EXTRAPYRAMIDAL DISORDER 30 0.0012
442 HEAD INJURY 38 0.0012
443 RASH PRURITIC 65 0.0012
444 BRAIN NEOPLASM 11 0.0012
445 RESPIRATORY TRACT CONGESTION 19 0.0012
446 HEART RATE INCREASED 118 0.0012
447 URINE ODOUR ABNORMAL 7 0.0012
448 DRUG USE DISORDER 10 0.0012
449 INFUSION SITE ERYTHEMA 10 0.0012
450 DRUG TOLERANCE 6 0.0012
451 DYSLIPIDAEMIA 6 0.0012
452 HEPATIC STEATOSIS 22 0.0012
453 MALAISE 518 0.0012
454 FLANK PAIN 11 0.0012
455 ROAD TRAFFIC ACCIDENT 49 0.0012
456 FOOT FRACTURE 22 0.0012
457 INTENTIONAL DOSE OMISSION 33 0.0012
458 THERAPEUTIC RESPONSE DECREASED 70 0.0012
459 LOWER LIMB FRACTURE 22 0.0011
460 BLOOD PRESSURE DECREASED 76 0.0011
461 SCRATCH 12 0.0011
462 NEPHROLITHIASIS 52 0.0011
463 SEASONAL ALLERGY 16 0.0011
464 PRODUCT DOSE OMISSION IN ERROR 32 0.0011
465 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 62 0.0011
466 EAR INFECTION 30 0.0011
467 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
468 FOOD POISONING 6 0.0011
469 THIRST 20 0.0011
470 LOCALISED INFECTION 27 0.0011
471 FEAR 30 0.0011
472 COVID-19 195 0.0011
473 FRACTURE 21 0.0011
474 PARAESTHESIA ORAL 16 0.0011
475 PHOTOPSIA 7 0.0011
476 SKIN LACERATION 12 0.0011
477 WEIGHT DECREASED 308 0.0011
478 ASPIRATION 12 0.0011
479 HYPOPHAGIA 28 0.0011
480 INTENTIONAL UNDERDOSE 8 0.0011
481 DELIRIUM 38 0.0011
482 HYPOTHERMIA 11 0.0011
483 ERUCTATION 21 0.0011
484 PSYCHIATRIC SYMPTOM 8 0.0011
485 OFF LABEL USE 948 0.0011
486 RASH GENERALISED 28 0.0011
487 DEHYDRATION 143 0.0011
488 CARPAL TUNNEL SYNDROME 15 0.0011
489 HYPERGLYCAEMIA 39 0.0011
490 KIDNEY INFECTION 21 0.0011
491 LIMB INJURY 29 0.0011
492 BRONCHITIS 79 0.0011
493 VERTIGO 65 0.0011
494 TEMPERATURE INTOLERANCE 11 0.0011
495 POOR VENOUS ACCESS 11 0.0011
496 STATUS EPILEPTICUS 12 0.0011
497 HYPOAESTHESIA ORAL 16 0.0011
498 PRODUCT FORMULATION ISSUE 7 0.0011
499 ABNORMAL BEHAVIOUR 42 0.0011
500 IMPAIRED DRIVING ABILITY 12 0.0011
501 HYPERKALAEMIA 37 0.0011
502 PRODUCT AVAILABILITY ISSUE 24 0.0011
503 ABNORMAL WEIGHT GAIN 13 0.0011
504 CHOLECYSTECTOMY 12 0.0010
505 EPILEPSY 32 0.0010
506 LIPASE INCREASED 8 0.0010
507 QUALITY OF LIFE DECREASED 14 0.0010
508 EXERCISE TOLERANCE DECREASED 6 0.0010
509 PRODUCT ADMINISTRATION ERROR 21 0.0010
510 BLOOD POTASSIUM DECREASED 31 0.0010
511 NEURALGIA 25 0.0010
512 RASH PAPULAR 23 0.0010
513 AUTOIMMUNE DISORDER 10 0.0010
514 VISUAL IMPAIRMENT 127 0.0010
515 VITREOUS FLOATERS 10 0.0010
516 CONFUSIONAL STATE 164 0.0010
517 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
518 SINUS DISORDER 20 0.0010
519 INTERVERTEBRAL DISC PROTRUSION 22 0.0010
520 GASTROINTESTINAL INFECTION 9 0.0010
521 NASAL CONGESTION 59 0.0010
522 UPPER LIMB FRACTURE 20 0.0010
523 PYREXIA 347 0.0010
524 MOVEMENT DISORDER 32 0.0010
525 DYSGEUSIA 74 0.0010
526 SINUSITIS 102 0.0010
527 MUSCLE DISORDER 8 0.0010
528 URTICARIA 165 0.0010
529 SOPOR 13 0.0010
530 IRRITABLE BOWEL SYNDROME 21 0.0010
531 TENDON RUPTURE 12 0.0010
532 PRODUCT DISTRIBUTION ISSUE 9 0.0010
533 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
534 VISUAL FIELD DEFECT 7 0.0010
535 EXPOSURE DURING PREGNANCY 60 0.0010
536 THERAPEUTIC RESPONSE SHORTENED 32 0.0010
537 VENTRICULAR EXTRASYSTOLES 10 0.0010
538 DIARRHOEA HAEMORRHAGIC 9 0.0010
539 FAECES SOFT 7 0.0010
540 CONTRAINDICATED PRODUCT ADMINISTERED 29 0.0010
541 HYPOAESTHESIA 143 0.0010
542 POISONING 12 0.0010
543 GALLBLADDER DISORDER 17 0.0010
544 BLINDNESS TRANSIENT 7 0.0009
545 INCONTINENCE 10 0.0009
546 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 170 0.0009
547 EYE SWELLING 35 0.0009
548 BREAST PAIN 10 0.0009
549 FEELING COLD 26 0.0009
550 GENITAL HAEMORRHAGE 12 0.0009
551 TREATMENT FAILURE 77 0.0009
552 CARDIAC FLUTTER 6 0.0009
553 PHARYNGITIS STREPTOCOCCAL 10 0.0009
554 RIB FRACTURE 19 0.0009
555 PHARYNGEAL SWELLING 9 0.0009
556 PSORIATIC ARTHROPATHY 37 0.0009
557 RHABDOMYOLYSIS 38 0.0009
558 TOOTH INFECTION 12 0.0009
559 VENTRICULAR TACHYCARDIA 15 0.0009
560 FOOD ALLERGY 7 0.0009
561 NOCTURIA 11 0.0009
562 ADVERSE REACTION 12 0.0009
563 LETHARGY 52 0.0009
564 PARAESTHESIA 142 0.0009
565 PRODUCT DOSE OMISSION ISSUE 265 0.0009
566 LIP SWELLING 30 0.0009
567 NERVE INJURY 10 0.0009
568 MALNUTRITION 10 0.0009
569 PERICARDITIS 15 0.0009
570 THERAPEUTIC RESPONSE UNEXPECTED 40 0.0009
571 MUSCULOSKELETAL STIFFNESS 78 0.0009
572 PHARYNGITIS 11 0.0009
573 OROPHARYNGEAL DISCOMFORT 8 0.0009
574 DRUG INEFFECTIVE 1165 0.0009
575 DISORIENTATION 35 0.0009
576 LOSS OF CONSCIOUSNESS 113 0.0009
577 ALOPECIA 173 0.0009
578 PNEUMONIA ASPIRATION 22 0.0009
579 ADVERSE EVENT 81 0.0009
580 SECRETION DISCHARGE 11 0.0009
581 EAR DISCOMFORT 9 0.0009
582 INTERNAL HAEMORRHAGE 10 0.0009
583 ECCHYMOSIS 6 0.0009
584 GASTRITIS 23 0.0009
585 PULMONARY MASS 13 0.0009
586 ORAL HERPES 17 0.0009
587 INCREASED TENDENCY TO BRUISE 8 0.0009
588 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
589 MENTAL STATUS CHANGES 24 0.0009
590 ECONOMIC PROBLEM 13 0.0009
591 INTENTIONAL PRODUCT USE ISSUE 75 0.0009
592 BLOOD PRESSURE ABNORMAL 17 0.0009
593 ABNORMAL FAECES 7 0.0009
594 EYE DISORDER 28 0.0009
595 PRODUCT SUBSTITUTION ISSUE 49 0.0009
596 DYSARTHRIA 32 0.0008
597 RESPIRATORY TRACT INFECTION 22 0.0008
598 INFLUENZA 94 0.0008
599 BLOOD URINE PRESENT 16 0.0008
600 HEREDITARY ANGIOEDEMA 9 0.0008
601 HOT FLUSH 63 0.0008
602 DISCOMFORT 51 0.0008
603 ATRIAL SEPTAL DEFECT 7 0.0008
604 GLAUCOMA 16 0.0008
605 HYPERTHYROIDISM 12 0.0008
606 RASH 361 0.0008
607 INADEQUATE ANALGESIA 7 0.0008
608 EAR PAIN 16 0.0008
609 DYSPNOEA 465 0.0008
610 FACIAL PARALYSIS 7 0.0008
611 CHOKING 16 0.0008
612 VITAMIN D DECREASED 7 0.0008
613 DENTAL CARIES 9 0.0008
614 MUSCULOSKELETAL DISCOMFORT 14 0.0008
615 OVERDOSE 175 0.0008
616 URINARY INCONTINENCE 24 0.0008
617 KNEE ARTHROPLASTY 17 0.0008
618 BLADDER DISORDER 8 0.0008
619 GINGIVAL BLEEDING 11 0.0008
620 HAIR COLOUR CHANGES 10 0.0008
621 SPEECH DISORDER 42 0.0008
622 DRY EYE 40 0.0008
623 FISTULA 9 0.0008
624 SPINAL OSTEOARTHRITIS 7 0.0008
625 JOINT INJURY 17 0.0008
626 IMMUNOSUPPRESSION 7 0.0008
627 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
628 POLLAKIURIA 33 0.0008
629 OSTEOPENIA 12 0.0008
630 CHRONIC KIDNEY DISEASE 60 0.0008
631 APHONIA 11 0.0008
632 PHOTOSENSITIVITY REACTION 13 0.0008
633 GASTRIC DISORDER 27 0.0008
634 ABDOMINAL DISTENSION 82 0.0008
635 CYSTITIS 25 0.0008
636 HYPOTHYROIDISM 25 0.0008
637 DYSPEPSIA 77 0.0008
638 PRODUCT PRESCRIBING ISSUE 17 0.0008
639 MUSCLE SPASMS 143 0.0008
640 ROTATOR CUFF SYNDROME 10 0.0008
641 TRANSIENT ISCHAEMIC ATTACK 26 0.0008
642 FEELING HOT 47 0.0008
643 EXOSTOSIS 7 0.0008
644 PRODUCT DOSE OMISSION 50 0.0008
645 URINARY TRACT INFECTION 130 0.0008
646 PRODUCT USE COMPLAINT 12 0.0008
647 ANKYLOSING SPONDYLITIS 10 0.0008
648 BLOOD IRON DECREASED 9 0.0008
649 NERVE COMPRESSION 7 0.0008
650 IRON DEFICIENCY ANAEMIA 7 0.0008
651 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
652 DISEASE RECURRENCE 36 0.0008
653 DYSMENORRHOEA 10 0.0008
654 SWELLING FACE 49 0.0008
655 SENSORY DISTURBANCE 12 0.0007
656 INTESTINAL OBSTRUCTION 28 0.0007
657 FEMUR FRACTURE 23 0.0007
658 INFLUENZA LIKE ILLNESS 61 0.0007
659 FREQUENT BOWEL MOVEMENTS 20 0.0007
660 DRUG RESISTANCE 19 0.0007
661 NEUROPATHY PERIPHERAL 70 0.0007
662 PULMONARY THROMBOSIS 8 0.0007
663 NASOPHARYNGITIS 135 0.0007
664 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
665 HERNIA 14 0.0007
666 TOOTH EXTRACTION 9 0.0007
667 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
668 THYROID DISORDER 11 0.0007
669 BURNING SENSATION 50 0.0007
670 MENORRHAGIA 14 0.0007
671 NEPHROPATHY TOXIC 8 0.0007
672 CHEST PAIN 132 0.0007
673 HEPATIC CYTOLYSIS 9 0.0007
674 TOXICITY TO VARIOUS AGENTS 119 0.0007
675 MUSCULAR WEAKNESS 80 0.0007
676 OROPHARYNGEAL PAIN 65 0.0007
677 ANGIOEDEMA 31 0.0007
678 MULTIPLE SCLEROSIS RELAPSE 48 0.0007
679 ASTHMA 79 0.0007
680 PERIPHERAL SWELLING 107 0.0007
681 INJECTION SITE INDURATION 9 0.0007
682 HYPOTENSION 139 0.0007
683 ENCEPHALOPATHY 17 0.0007
684 TASTE DISORDER 14 0.0007
685 NODULE 9 0.0007
686 SKIN DISORDER 23 0.0007
687 DIVERTICULITIS 19 0.0007
688 DYSPHAGIA 65 0.0007
689 EYE PRURITUS 23 0.0007
690 GASTRIC ULCER 13 0.0007
691 ORAL CANDIDIASIS 9 0.0007
692 NECK PAIN 38 0.0007
693 FLUSHING 69 0.0007
694 POST PROCEDURAL COMPLICATION 13 0.0007
695 ABDOMINAL PAIN LOWER 17 0.0007
696 JOINT RANGE OF MOTION DECREASED 9 0.0007
697 HAEMATOCHEZIA 37 0.0007
698 MACULAR DEGENERATION 8 0.0007
699 MULTIPLE SCLEROSIS 32 0.0007
700 WEIGHT FLUCTUATION 7 0.0007
701 PAIN OF SKIN 18 0.0007
702 VAGINAL HAEMORRHAGE 29 0.0007
703 HYPERTENSION 141 0.0007
704 RHINORRHOEA 43 0.0007
705 BACK PAIN 154 0.0007
706 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
707 TREATMENT NONCOMPLIANCE 36 0.0007
708 PERIPHERAL COLDNESS 9 0.0007
709 BODY HEIGHT DECREASED 7 0.0007
710 OCULAR HYPERAEMIA 31 0.0007
711 CANDIDA INFECTION 11 0.0007
712 INJECTION SITE MASS 24 0.0006
713 ABORTION SPONTANEOUS 26 0.0006
714 LIMB DISCOMFORT 20 0.0006
715 MUSCULOSKELETAL CHEST PAIN 10 0.0006
716 ILEUS 8 0.0006
717 BLOOD CHOLESTEROL INCREASED 30 0.0006
718 CEREBRAL HAEMORRHAGE 23 0.0006
719 SWOLLEN TONGUE 20 0.0006
720 OSTEOARTHRITIS 27 0.0006
721 ANAPHYLACTIC REACTION 35 0.0006
722 VENTRICULAR FIBRILLATION 7 0.0006
723 TOOTH DISORDER 14 0.0006
724 RASH MACULAR 22 0.0006
725 HYPERTENSIVE CRISIS 7 0.0006
726 PANCREATITIS 33 0.0006
727 COLD SWEAT 11 0.0006
728 THROAT IRRITATION 28 0.0006
729 PAIN 382 0.0006
730 EYE INFECTION 7 0.0006
731 NEEDLE ISSUE 18 0.0006
732 GASTROENTERITIS 9 0.0006
733 SKIN FISSURES 12 0.0006
734 JOINT STIFFNESS 16 0.0006
735 BEDRIDDEN 8 0.0006
736 ATRIAL FIBRILLATION 59 0.0006
737 SARS-COV-2 TEST POSITIVE 8 0.0006
738 COLITIS ULCERATIVE 27 0.0006
739 EYELID OEDEMA 7 0.0006
740 INFLAMMATION 31 0.0006
741 PAIN IN JAW 17 0.0006
742 FUNGAL INFECTION 20 0.0006
743 SEPTIC SHOCK 26 0.0006
744 LACRIMATION INCREASED 18 0.0006
745 CHEST DISCOMFORT 61 0.0006
746 CELLULITIS 30 0.0006
747 CORONARY ARTERY DISEASE 18 0.0006
748 UPPER GASTROINTESTINAL HAEMORRHAGE 10 0.0006
749 AGRANULOCYTOSIS 11 0.0006
750 UVEITIS 8 0.0006
751 HIP ARTHROPLASTY 9 0.0006
752 HYPERLIPIDAEMIA 7 0.0006
753 TENDONITIS 9 0.0006
754 UNRESPONSIVE TO STIMULI 15 0.0006
755 COLITIS 22 0.0006
756 HAEMATOMA 15 0.0006
757 IMPAIRED HEALING 19 0.0006
758 ORAL DISCOMFORT 8 0.0006
759 HEART RATE IRREGULAR 13 0.0006
760 EPISTAXIS 43 0.0006
761 MUSCLE SPASTICITY 7 0.0006
762 DRUG INTOLERANCE 55 0.0006
763 SMALL INTESTINAL OBSTRUCTION 7 0.0006
764 SKIN REACTION 8 0.0006
765 HYPERCALCAEMIA 7 0.0006
766 SKIN DISCOLOURATION 26 0.0006
767 DRUG ABUSE 47 0.0006
768 TYPE 2 DIABETES MELLITUS 19 0.0006
769 GAIT DISTURBANCE 108 0.0006
770 HAEMORRHOIDS 11 0.0006
771 CARDIAC ARREST 46 0.0006
772 NEOPLASM MALIGNANT 37 0.0006
773 TOOTHACHE 10 0.0006
774 BACK INJURY 6 0.0006
775 PRODUCT DISPENSING ERROR 12 0.0006
776 DRUG WITHDRAWAL SYNDROME 48 0.0005
777 THROMBOSIS 44 0.0005
778 ARTHRITIS 43 0.0005
779 INFECTION 79 0.0005
780 PRODUCT PHYSICAL ISSUE 11 0.0005
781 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
782 FOOT DEFORMITY 6 0.0005
783 HYPERSENSITIVITY 100 0.0005
784 DEEP VEIN THROMBOSIS 35 0.0005
785 EYE IRRITATION 31 0.0005
786 UNEVALUABLE EVENT 40 0.0005
787 ARRHYTHMIA 25 0.0005
788 DRUG DISPENSING ERROR 8 0.0005
789 MOUTH ULCERATION 11 0.0005
790 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 37 0.0005
791 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
792 OXYGEN SATURATION DECREASED 29 0.0005
793 MUSCULOSKELETAL PAIN 27 0.0005
794 HEPATIC ENZYME INCREASED 35 0.0005
795 NERVOUS SYSTEM DISORDER 16 0.0005
796 DRUG-INDUCED LIVER INJURY 16 0.0005
797 ACUTE KIDNEY INJURY 78 0.0005
798 COVID-19 PNEUMONIA 6 0.0005
799 FAECES DISCOLOURED 11 0.0005
800 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
801 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
802 CHOLECYSTITIS 6 0.0005
803 RASH ERYTHEMATOUS 24 0.0005
804 CEREBROVASCULAR ACCIDENT 85 0.0005
805 PNEUMONIA 161 0.0005
806 PELVIC PAIN 9 0.0005
807 DERMATITIS ATOPIC 26 0.0005
808 ACCIDENTAL OVERDOSE 18 0.0005
809 RECTAL HAEMORRHAGE 21 0.0005
810 CHROMATURIA 11 0.0005
811 CATARACT 29 0.0005
812 PRODUCT PREPARATION ERROR 10 0.0005
813 CYST 6 0.0005
814 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
815 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
816 EMOTIONAL DISTRESS 58 0.0005
817 RESPIRATORY DISTRESS 13 0.0005
818 SWELLING 44 0.0005
819 ACUTE RESPIRATORY FAILURE 9 0.0005
820 RENAL FAILURE 62 0.0005
821 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
822 HAEMOPTYSIS 13 0.0005
823 LIVER FUNCTION TEST INCREASED 10 0.0005
824 DEAFNESS 12 0.0005
825 HEPATIC FUNCTION ABNORMAL 17 0.0005
826 HYPOKALAEMIA 21 0.0005
827 LYMPHOCYTE COUNT DECREASED 8 0.0005
828 EYE HAEMORRHAGE 6 0.0004
829 DRY SKIN 60 0.0004
830 ORAL PAIN 10 0.0004
831 DRUG EFFECT DECREASED 24 0.0004
832 THROAT TIGHTNESS 12 0.0004
833 PNEUMOTHORAX 7 0.0004
834 PALLOR 12 0.0004
835 ULCER 7 0.0004
836 ECZEMA 23 0.0004
837 SCIATICA 7 0.0004
838 ACUTE HEPATIC FAILURE 6 0.0004
839 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
840 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
841 HERPES ZOSTER 25 0.0004
842 BRADYCARDIA 23 0.0004
843 PROCEDURAL PAIN 12 0.0004
844 COORDINATION ABNORMAL 6 0.0004
845 PSORIASIS 56 0.0004
846 CHOLELITHIASIS 14 0.0004
847 ANAPHYLACTIC SHOCK 11 0.0004
848 PAIN IN EXTREMITY 125 0.0004
849 GAIT INABILITY 14 0.0004
850 CHOLESTASIS 8 0.0004
851 BLOOD PRESSURE FLUCTUATION 10 0.0004
852 GENERAL PHYSICAL HEALTH DETERIORATION 48 0.0004
853 BLOOD CREATININE INCREASED 27 0.0004
854 HEMIPARESIS 7 0.0004
855 DRUG EFFECT INCOMPLETE 15 0.0004
856 FLUID RETENTION 21 0.0004
857 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
858 DYSSTASIA 12 0.0004
859 RASH MACULO-PAPULAR 9 0.0004
860 HIP FRACTURE 13 0.0004
861 COLON CANCER 6 0.0004
862 AGEUSIA 10 0.0004
863 HEART RATE DECREASED 14 0.0004
864 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
865 ACNE 30 0.0004
866 CARDIAC DISORDER 37 0.0004
867 DRUG ERUPTION 7 0.0004
868 GASTROINTESTINAL HAEMORRHAGE 33 0.0004
869 SKIN IRRITATION 18 0.0004
870 DRUG DEPENDENCE 63 0.0004
871 HEPATITIS 10 0.0004
872 INJECTION SITE WARMTH 8 0.0004
873 INTENTIONAL PRODUCT MISUSE 34 0.0004
874 CARDIAC FAILURE 31 0.0004
875 INCORRECT DOSE ADMINISTERED 88 0.0004
876 RED BLOOD CELL COUNT DECREASED 11 0.0004
877 BONE DISORDER 7 0.0004
878 ANGINA PECTORIS 11 0.0004
879 END STAGE RENAL DISEASE 7 0.0004
880 INJECTION SITE ERYTHEMA 47 0.0004
881 INJECTION SITE REACTION 26 0.0004
882 ARTHROPATHY 21 0.0004
883 INFUSION RELATED REACTION 25 0.0004
884 ABSCESS 6 0.0004
885 INJECTION SITE PRURITUS 25 0.0004
886 JOINT SWELLING 45 0.0004
887 MYOCARDIAL INFARCTION 65 0.0004
888 RENAL INJURY 11 0.0004
889 EXTRA DOSE ADMINISTERED 15 0.0004
890 PREMATURE BABY 11 0.0004
891 RENAL DISORDER 17 0.0004
892 SKIN LESION 10 0.0004
893 RESPIRATORY ARREST 10 0.0004
894 EXPIRED PRODUCT ADMINISTERED 12 0.0004
895 DYSPHONIA 21 0.0004
896 PRODUCTIVE COUGH 17 0.0004
897 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
898 BONE DENSITY DECREASED 11 0.0004
899 SPINAL FRACTURE 7 0.0003
900 SKIN ULCER 9 0.0003
901 RENAL IMPAIRMENT 29 0.0003
902 LIVER FUNCTION TEST ABNORMAL 10 0.0003
903 LYMPHADENOPATHY 12 0.0003
904 TOOTH LOSS 7 0.0003
905 PULMONARY EMBOLISM 32 0.0003
906 STAPHYLOCOCCAL INFECTION 11 0.0003
907 FOETAL EXPOSURE DURING PREGNANCY 27 0.0003
908 OEDEMA 18 0.0003
909 ILL-DEFINED DISORDER 20 0.0003
910 DIABETES MELLITUS 25 0.0003
911 BLOOD GLUCOSE ABNORMAL 6 0.0003
912 BACTERIAL INFECTION 6 0.0003
913 BLISTER 18 0.0003
914 OEDEMA PERIPHERAL 39 0.0003
915 DYSPNOEA EXERTIONAL 12 0.0003
916 PRODUCT COMPLAINT 8 0.0003
917 STEVENS-JOHNSON SYNDROME 7 0.0003
918 STOMATITIS 19 0.0003
919 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
920 BLOOD GLUCOSE DECREASED 15 0.0003
921 HYPOXIA 11 0.0003
922 BREAST CANCER 29 0.0003
923 EXPOSURE VIA SKIN CONTACT 8 0.0003
924 HAEMORRHAGE 32 0.0003
925 LUNG DISORDER 15 0.0003
926 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
927 PERICARDIAL EFFUSION 7 0.0003
928 DRUG DOSE OMISSION 50 0.0003
929 HYPOACUSIS 13 0.0003
930 DEVICE ISSUE 27 0.0003
931 VIRAL INFECTION 10 0.0003
932 PNEUMONITIS 8 0.0003
933 DIABETIC KETOACIDOSIS 7 0.0003
934 DEATH 251 0.0003
935 RHEUMATOID ARTHRITIS 33 0.0003
936 DERMATITIS 6 0.0003
937 WOUND 8 0.0003
938 SKIN EXFOLIATION 24 0.0003
939 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
940 ERYTHEMA 57 0.0003
941 RESPIRATORY FAILURE 20 0.0003
942 OSTEONECROSIS 9 0.0003
943 BONE PAIN 16 0.0003
944 PLATELET COUNT DECREASED 29 0.0003
945 LIVER DISORDER 12 0.0003
946 INJURY 19 0.0003
947 LUNG NEOPLASM MALIGNANT 11 0.0003
948 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
949 INJECTION SITE PAIN 82 0.0003
950 INCORRECT DOSE ADMINISTERED BY DEVICE 7 0.0003
951 HEPATIC FAILURE 8 0.0003
952 APPLICATION SITE PRURITUS 6 0.0003
953 MENSTRUATION IRREGULAR 7 0.0003
954 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
955 FEBRILE NEUTROPENIA 17 0.0003
956 DEVICE DISLOCATION 11 0.0003
957 BLOOD GLUCOSE INCREASED 46 0.0002
958 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
959 WHEEZING 14 0.0002
960 NEUTROPENIA 32 0.0002
961 RESPIRATORY DISORDER 7 0.0002
962 INJECTION SITE RASH 7 0.0002
963 DEVICE BREAKAGE 9 0.0002
964 ANAEMIA 42 0.0002
965 THROMBOCYTOPENIA 23 0.0002
966 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
967 ACUTE MYOCARDIAL INFARCTION 6 0.0002
968 INJECTION SITE BRUISING 16 0.0002
969 LEUKOPENIA 10 0.0002
970 CARDIAC FAILURE CONGESTIVE 16 0.0002
971 INJECTION SITE SWELLING 15 0.0002
972 HAEMOGLOBIN DECREASED 20 0.0002
973 PRODUCT STORAGE ERROR 17 0.0002
974 INTERSTITIAL LUNG DISEASE 9 0.0002
975 SKIN BURNING SENSATION 13 0.0002
976 NEUTROPHIL COUNT DECREASED 7 0.0002
977 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
978 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
979 MATERNAL EXPOSURE DURING PREGNANCY 15 0.0002
980 C-REACTIVE PROTEIN INCREASED 6 0.0002
981 PULMONARY OEDEMA 7 0.0002
982 PRODUCT QUALITY ISSUE 21 0.0002
983 DEVICE LEAKAGE 6 0.0001
984 PLEURAL EFFUSION 8 0.0001
985 DISEASE PROGRESSION 15 0.0001
986 DEVICE MALFUNCTION 8 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
988 DEVICE EXPULSION 6 0.0001
989 MALIGNANT NEOPLASM PROGRESSION 8 0.0001